Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (3473)	4/20/2001 1:05:59 AM
From: scaram(o)uche	Respond to of 52153

Subject 51106

To: Miljenko Zuanic who wrote (3473)	4/20/2001 5:51:47 PM
From: Michael Young	Respond to of 52153

<<I do not like their methodology and way how they attack comps, where they are short. You want to profit from that, good. Wish you luck.>> I gotcha. So it is fine if a firm is paid a big I-banking fee to tout the hell out of a company with glowing reports? But doing independant research is just over the line? I'm sure you hate the big firms also. They have blown more than a few calls in their time as well. I don't always agree with firms such as Avalon. But I respect their work and don't get pissed if they dog a biotech I am long. In fact I welcome differing opinions. MIKE